It was only upon lymph node metastasis and further immunohistochemical review (including mutant-type p53, negative p16, and positive CK17 and SOX2) that dVIN was confirmed, suggesting a possible early microinvasive lesion that had been overlooked. Here, TP53 is linked to metastatic malignant neoplasm in the lymph nodes.